News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Voyager Therapeutics Presents Promising Parkinson’s Data


(October 5, 2017) - Voyager Therapeutics Inc released positive clinical data from an ongoing Phase 1b study evaluating its advanced Parkinson’s disease therapy. The drug, called VY-AADC01, is a gene therapy that was developed by Voyager to help boost patients’ abilities to produce dopamine. According to Voyager’s announcement, VY-AADC01 managed to spark durable, time-dependent and dose-dependent improvements in several metrics that assess Parkinson’s patients’ motor function – after just a single administration of the drug. Read more…